HCA Healthcare (HCA) Stock Fair Value Edges Higher After Mixed Analyst Target Changes

The latest update for HCA Healthcare points to a modestly higher fair value estimate, moving from about US$452.29 to about US$461.81, which works out to roughly a 2.1% change in the modeled price target. Street research links this shift to a blend of optimism around HCA Healthcare's long term project pipeline and cost execution, alongside caution on guidance resets, payor mix and procedure trends that keeps targets spread across a wide band. As you read on, you will see how to track this...